Paeoniflorin combined with norfloxacin ameliorates drug-resistant Streptococcus suis infection.

Jinpeng LiQingying FanJing ZuoBingqian XueXiaoling ZhangYing WeiLiyun SunDaniel GrenierLi YiXiaogai HouYang Wang

Published in: The Journal of antimicrobial chemotherapy (2022)

This study highlighted the inhibitory potential of paeoniflorin on the LuxS/AI-2 QS system of S. suis, and provided evidence that it can inhibit the FQ efflux pump and prevent biofilm formation to cooperate with norfloxacin in the treatment of resistant S. suis-related infections.

Keyphrases

biofilm formation
drug resistant
pseudomonas aeruginosa
candida albicans
staphylococcus aureus
multidrug resistant
acinetobacter baumannii
escherichia coli
artificial intelligence
cystic fibrosis
risk assessment
machine learning
climate change